Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hookipa Pharma Inc

1.24
-0.0150-1.20%
Volume:10.96K
Turnover:13.49K
Market Cap:14.89M
PE:-0.35
High:1.24
Open:1.23
Low:1.21
Close:1.25
Loading ...

HOOKIPA Pharma Inc. (“HOOKIPA”) Rule 2.9 Announcement – Amendment

GlobeNewswire
·
06 Jan

Hookipa Pharma, Poolberg Pharma in Discussions for All-Stock Merger

MT Newswires Live
·
02 Jan

Hookipa Pharma to acquire Poolbeg Pharma

TIPRANKS
·
02 Jan

BRIEF-Poolbeg Pharma Says Co In Talks For Its All-Share Acquisition By Hookipa

Reuters
·
02 Jan

Poolbeg Pharma: Under Terms Poolbeg Shareholders to Receive 0.03 HOOKIPA Shares for Each Poolbeg Share Held

THOMSON REUTERS
·
02 Jan

RBC Downgrades HOOKIPA Pharma to Sector Perform From Outperform, Slashes Price Target to $2 From $48, Keeps Speculative Risk

MT Newswires Live
·
20 Dec 2024

Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program

TipRanks
·
22 Nov 2024

Sector Update: Health Care Stocks Climb Thursday Afternoon

MT Newswires Live
·
22 Nov 2024

HOOKIPA Pharma to Cut Workforce by 80%, Shift Focus to KRAS Cancer Program

MT Newswires Live
·
21 Nov 2024

BRIEF-Hookipa Pharma Inc - On November 18 Approved Plan to Reduce Workforce By Approximately 80%

Reuters
·
21 Nov 2024

HOOKIPA Pharma - Restructuring Plan to Begin in Q4 2024, Complete by H1 2025

THOMSON REUTERS
·
21 Nov 2024

HOOKIPA Pharma - to Pause Clinical Development in Eseba-Vec Program

THOMSON REUTERS
·
21 Nov 2024

HOOKIPA Pharma - Early Termination of Hpv16+ Trial Not Due to Efficacy or Safety

THOMSON REUTERS
·
21 Nov 2024

HOOKIPA Pharma Inc - on November 18, Co Approved a Planto Reduce Workforce by Approximately 80%

THOMSON REUTERS
·
21 Nov 2024

HOOKIPA Pharma Inc: Will Focus Primarily on Progressing the Phase 1-Ready Hb-700 Program for the Treatment of Kras Mutant Cancers

THOMSON REUTERS
·
21 Nov 2024

Analysts Are Bullish on These Healthcare Stocks: Hookipa Pharma (HOOK), Cue Biopharma (CUE)

TIPRANKS
·
18 Nov 2024